Walleye Capital
KURA icon

Walleye Capital’s Kura Oncology KURA Stock Holding History

Walleye Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
221,205
+217,463
+5,811% +$1.87M 0.01% 1553
2025
Q4 		$38.9K Buy
+3,742
New +$39.3K ﹤0.01% 4138
2025
Q3 		– Sell
-414,322
Closed -$2.39M – 4830
2025
Q2 		$2.39M Sell
414,322
-90,535
-18% -$555K 0.01% 1376
2025
Q1 		$3.33M Sell
504,857
-31,461
-6% -$245K 0.02% 1069
2024
Q4 		$4.67M Sell
536,318
-35,047
-6% -$504K 0.01% 1123
2024
Q3 		$11.2M Buy
571,365
+496,284
+661% +$10.1M 0.02% 628
2024
Q2 		$1.55M Sell
75,081
-8,171
-10% -$168K ﹤0.01% 2364
2024
Q1 		$1.78M Buy
83,252
+37,710
+83% +$733K ﹤0.01% 2079
2023
Q4 		$655K Sell
45,542
-219,351
-83% -$2.16M ﹤0.01% 2727
2023
Q3 		$2.42M Buy
264,893
+182,221
+220% +$1.85M 0.01% 1586
2023
Q2 		$875K Buy
+82,672
New +$978K ﹤0.01% 1962
2022
Q4 		– Sell
-268,074
Closed -$3.66M – 3426
2022
Q3 		$3.66M Buy
+268,074
New +$4.13M 0.07% 306
2021
Q3 		– Sell
-20,990
Closed -$438 – 1709
2021
Q2 		$438 Buy
+20,990
New +$521K 0.01% 811
2018
Q3 		$1.05M Buy
+59,932
New +$1.15M 0.49% 60

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's KURA Position: Q1 2026 in Review

Walleye Capital increased its Kura Oncology (KURA) stake by 5,811% in Q1 2026, buying an estimated $1.87M and bringing the position to 221,205 shares worth $1.8M. The position accounts for 0.01% of the portfolio, ranked #1553.

Walleye Capital first reported a position in KURA in Q3 2018 and has held it in 14 quarters since. The position peaked at $11.2M in Q3 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Walleye Capital held 221,205 shares of Kura Oncology worth $1.8M as of Q1 2026.
  • Walleye Capital bought 217,463 Kura Oncology shares in Q1 2026, an estimated $1.87M.
  • Kura Oncology made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1553 holding.
  • Walleye Capital first reported a position in Kura Oncology in Q3 2018 and has held it in 14 quarters since.
  • Walleye Capital's Kura Oncology position peaked at $11.2M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.